Sign in
Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy ( IMSAT ) therapeutic drug monitoring study
Journal article   Open access  Peer reviewed

Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy ( IMSAT ) therapeutic drug monitoring study

Neil Chanchlani, Simeng Lin, Marcus K. Auth, Chai Leng Lee, Helena Robbins, Shi Looi, Senthil V. Murugesan, Tom Riley, Cathryn Preston, Sophie Stephenson, …
Alimentary pharmacology & therapeutics, Vol.56(8), pp.1250-1263
10/2022
PMID: 36039036
url
https://doi.org/10.1111/apt.17170View
Published (Version of record) Open

Metrics

1 Record Views

Details